Jeffrey W. Sherman - Jul 28, 2021 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co (HZNP)

Role
EVP and Chief Medical Officer
Signature
/s/ Miles W. McHugh, Attorney-in-Fact
Stock symbol
HZNP
Transactions as of
Jul 28, 2021
Transactions value $
-$329,538
Form type
4
Date filed
7/30/2021, 04:27 PM
Previous filing
Jul 2, 2021
Next filing
Sep 23, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Award $0 +7.26K +79.62% $0.00 16.4K Jul 28, 2021 Direct F1
transaction HZNP Ordinary Shares Tax liability -$330K -3.22K -19.64% $102.50 13.2K Jul 28, 2021 Direct
holding HZNP Ordinary Shares 66.7K Jul 28, 2021 By Spouse
holding HZNP Ordinary Shares 129K Jul 28, 2021 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HZNP Performance Restricted Stock Units (PSUs) Award $0 +14.5K $0.00 14.5K Jul 28, 2021 Ordinary Shares 14.5K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On January 3, 2020, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On July 28, 2021, such performance criteria were met, and the PSUs vested as to the number of shares reported in Table I above. The remaining ordinary shares subject to the PSUs vest in equal annual installments on January 5, 2022 and January 5, 2023.
F2 Each PSU represents a contingent right to receive one ordinary share of the Issuer.